Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva and radiation therapy in locally advanced head and neck cancer
NCT01192815Phase 2Terminated
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jan 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Case Comprehensive Cancer Center. Started Jan 2011; status: terminated.
02
Drugs
erlotinib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01192815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192815.